Press releases

Press release 2020-07-03

First study group has been dosed in Xspray Pharma’s ongoing pivotal registration studies with HyNap-Dasa

Press release 2020-06-25

Xspray – Virtual Capital Markets Day today at 14.00 CET

Press release 2020-06-18

Invitation to virtual Capital Markets Day with Xspray on June 25 at 14.00-15.30 CET

Regulatory press release 2020-05-29

Xspray Pharma initiates pivotal registration studies with HyNap-Dasa for the market approval application in the United States

Regulatory press release 2020-05-14

Bulletin from the annual general meeting of Xspray Pharma AB (publ)

All press releases

Latest report
Interim Report Q1 2020
Subscribe
Get our latest press releases and reports
Subscribe
Submit to our press releases and get an email every time we publish a press release or report on our website.
Type*
Reports
Press releases
E-mail*

Välj språk*
Swedish
English
When clicked on Send I agree that my personal information will be saved. Read more
Phone
This field is for validation purposes and should be left unchanged.
Upcoming calendar events
31 July 2020 – Interim report, Apr-Jun, 2020

Press contact

Per Andersson, CEO

+46 (0)8 730 37 00

per.andersson@xspray.com

Media